upcoming news, page-2

hi hyosuk

This is my understanding of what's coming up for PRR that we know about:


Phase 11b will start by end of this year and will take 2 years with interim data by approx Dec 2010

Orphan Drug Status expected by Feb next year

Phase 111 will start approx Dec 2010 in Europe
(not sure how long this will take-2-3 years?)

As we saw today with the cervical cancer vaccine announcement and the recent change in the Springtree funding arrangements, there are also other possible developments which sometimes come as a surprise and which are good news for us the shareholders and the health community.

The management are keepng on their toes and the latest analyst report by Southern Cross (found on the PRR website) predicting a share price in the range 60c to $1.14 in the next 12 months points to the great value and potential of this comany.

regards
Birdseye